SubHero Banner
Text

February 2025

Core topics in this month’s edition include:

  • Onapgo™ (apomorphine) – New drug approval
  • Susvimo® (ranibizumab) – New indication
  • Purixan® (mercaptopurine) – First-time generic

Download

Text